CD Media

Moderna ‘Shocked’ After FDA Scuttles Review Of New mRNA Flu Vaccine

2 weeks 4 days ago
The FDA last week notified Moderna that the agency would not review its application for a new mRNA flu vaccine, citing the company’s failure to perform an “adequate and well-controlled” clinical trial. Experts suggested the FDA may be signaling skepticism of mRNA vaccines in general.
Children's Health Defense
Checked
57 minutes 50 seconds ago
CD Media
Human Reporters • Not Machines
Subscribe to CD Media feed